U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 652

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr9:36276916
GRCh38:
Chr9:36276919
GNER9TSialuria, GNE myopathyUncertain significance
(Jun 26, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr9:36229008-36236991
GNEGNE myopathy, SialuriaLikely pathogenic
(Oct 24, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr9:36246018-36249404
GNEGNE myopathy, SialuriaLikely pathogenic
(Aug 24, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr9:36227225-36276941
GNEGNE myopathy, SialuriaPathogenic
(Sep 1, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr9:36246008-36276941
GNEGNE myopathy, SialuriaPathogenic
(Feb 19, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr9:36246018-36246489
GNEGNE myopathy, SialuriaPathogenic
(Nov 21, 2021)
criteria provided, single submitter
7.
GRCh37:
Chr9:36249182
GRCh38:
Chr9:36249185
GNEGNE myopathy, SialuriaLikely benign
(Mar 19, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr9:36234059
GRCh38:
Chr9:36234062
GNEGNE myopathy, SialuriaLikely benign
(Jul 19, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr9:36222928
GRCh38:
Chr9:36222931
GNEQ383H, Q434H, Q442H, Q493H, Q524HGNE myopathy, SialuriaUncertain significance
(Aug 6, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr9:36222897
GRCh38:
Chr9:36222900
GNEL394V, L445V, L453V, L504V, L535VSialuria, GNE myopathyUncertain significance
(Mar 19, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr9:36223404
GRCh38:
Chr9:36223407
GNEE400D, E408D, E459D, E490D, E349DGNE myopathy, SialuriaUncertain significance
(Aug 31, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr9:36249275
GRCh38:
Chr9:36249278
GNEGNE myopathy, SialuriaLikely benign
(May 18, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr9:36222868
GRCh38:
Chr9:36222871
GNEW403*, W544*, W454*, W462*, W513*Sialuria, GNE myopathy, not provided
Pathogenic
(Sep 23, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr9:36249173
GRCh38:
Chr9:36249176
GNESialuria, GNE myopathyLikely benign
(Jun 20, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr9:36220028
GRCh38:
Chr9:36220031
GNESialuria, GNE myopathyLikely benign
(Aug 22, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr9:36246039
GRCh38:
Chr9:36246042
GNER143H, R202H, R233HSialuria, GNE myopathyUncertain significance
(Jan 4, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr9:36223518
GRCh38:
Chr9:36223521
GNESialuria, GNE myopathyLikely benign
(Mar 19, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr9:36227399
GRCh38:
Chr9:36227402
GNES266F, S407F, S317F, S376F, S325FSialuria, GNE myopathyUncertain significance
(Oct 19, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr9:36249251
GRCh38:
Chr9:36249254
GNESialuria, GNE myopathyLikely benign
(Oct 14, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr9:36219919
GRCh38:
Chr9:36219922
GNED468H, D519H, D578H, D504H, D609H, D527HGNE myopathy, SialuriaUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr9:36219991
GRCh38:
Chr9:36219994
GNEH480Y, H585Y, H444Y, H554Y, H503Y, H495YSialuria, GNE myopathy, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(May 26, 2023)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr9:36234020
GRCh38:
Chr9:36234023
GNEGNE myopathy, SialuriaLikely benign
(Mar 6, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr9:36223516-36223517
GRCh38:
Chr9:36223519-36223520
GNESialuria, GNE myopathyLikely benign
(Oct 23, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr9:36234055
GRCh38:
Chr9:36234058
GNEV282I, V172I, V223I, V231I, V313ISialuria, GNE myopathyUncertain significance
(Jun 15, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr9:36217371
GRCh38:
Chr9:36217374
GNEGNE myopathy, SialuriaLikely benign
(Dec 17, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr9:36276880
GRCh38:
Chr9:36276883
GNESialuria, GNE myopathyLikely benign
(May 22, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr9:36217381
GRCh38:
Chr9:36217384
GNET643R, T748R, T666R, T658R, T607R, T717RSialuria, GNE myopathyUncertain significance
(Aug 24, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr9:36222993
GRCh38:
Chr9:36222996
GNEI413V, I421V, I503V, I362V, I472VSialuria, GNE myopathyUncertain significance
(Sep 17, 2021)
criteria provided, single submitter
29.
GRCh37:
Chr9:36227235
GRCh38:
Chr9:36227238
GNESialuria, GNE myopathyLikely benign
(Jun 11, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr9:36246024
GRCh38:
Chr9:36246027
GNESialuria, GNE myopathyUncertain significance
(Apr 23, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr9:36219896
GRCh38:
Chr9:36219899
GNESialuria, GNE myopathyLikely benign
(Mar 4, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr9:36249246
GRCh38:
Chr9:36249249
GNEP36H, P67HSialuria, GNE myopathyUncertain significance
(Aug 7, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr9:36223513-36223514
GRCh38:
Chr9:36223516-36223517
GNEGNE myopathy, SialuriaLikely benign
(Oct 18, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr9:36246088
GRCh38:
Chr9:36246091
GNEY217H, Y127H, Y186HGNE myopathy, SialuriaPathogenic
(Jan 26, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr9:36236976
GRCh38:
Chr9:36236979
GNED208N, D149N, D239NGNE myopathy, SialuriaLikely pathogenic
(Jul 1, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr9:36217507
GRCh38:
Chr9:36217510
GNEY565C, Y706C, Y601C, Y616C, Y624C, Y675CGNE myopathy, SialuriaUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr9:36219827
GRCh38:
Chr9:36219830
GNEGNE myopathy, SialuriaLikely benign
(Dec 12, 2021)
criteria provided, single submitter
38.
GRCh37:
Chr9:36236864
GRCh38:
Chr9:36236867
GNEK186T, K245T, K276Tnot provided, GNE myopathy, Sialuria
Uncertain significance
(May 3, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr9:36229113
GRCh38:
Chr9:36229116
GNEGNE myopathy, SialuriaLikely benign
(May 1, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr9:36249241
GRCh38:
Chr9:36249244
GNEF69L, F38LSialuria, GNE myopathyUncertain significance
(Apr 22, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr9:36217541
GRCh38:
Chr9:36217544
GNESialuria, GNE myopathyPathogenic
(Apr 30, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr9:36229050
GRCh38:
Chr9:36229053
GNESialuria, GNE myopathyLikely benign
(Apr 15, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr9:36276920
GRCh38:
Chr9:36276923
GNEQ8*Sialuria, GNE myopathyPathogenic
(Apr 4, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr9:36249358
GRCh38:
Chr9:36249361
GNEQ30KSialuria, GNE myopathyUncertain significance
(Apr 10, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr9:36218314
GRCh38:
Chr9:36218317
GNESialuria, GNE myopathyLikely benign
(Apr 1, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr9:36223501-36223502
GRCh38:
Chr9:36223504-36223505
GNESialuria, GNE myopathyUncertain significance
(Mar 29, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr9:36246401
GRCh38:
Chr9:36246404
GNESialuria, GNE myopathyLikely benign
(Mar 26, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr9:36223458
GRCh38:
Chr9:36223461
GNESialuria, GNE myopathyLikely benign
(Sep 22, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr9:36218241
GRCh38:
Chr9:36218244
GNESialuria, GNE myopathyLikely benign
(Mar 19, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr9:36222919
GRCh38:
Chr9:36222922
GNESialuria, GNE myopathyLikely benign
(Mar 23, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr9:36217396
GRCh38:
Chr9:36217399
GNEM661fs, M653fs, M638fs, M602fs, M712fs, M743fsSialuria, GNE myopathyPathogenic
(Mar 9, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr9:36223515-36223516
GRCh38:
Chr9:36223518-36223519
GNEGNE myopathy, SialuriaLikely benign
(Aug 25, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr9:36219892
GRCh38:
Chr9:36219895
GNEI528V, I477V, I587V, I618V, I513V, I536VGNE myopathy, SialuriaUncertain significance
(Feb 22, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr9:36249252
GRCh38:
Chr9:36249255
GNET34S, T65SGNE myopathy, SialuriaUncertain significance
(Mar 18, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr9:36223394
GRCh38:
Chr9:36223397
GNEGNE myopathy, SialuriaLikely benign
(Feb 5, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr9:36222835
GRCh38:
Chr9:36222838
GNEGNE myopathy, SialuriaLikely benign
(Jan 22, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr9:36218300
GRCh38:
Chr9:36218303
GNEGNE myopathy, SialuriaLikely benign
(Jan 17, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr9:36236848
GRCh38:
Chr9:36236851
GNEGNE myopathy, SialuriaLikely benign
(Oct 12, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr9:36220023
GRCh38:
Chr9:36220026
GNEGNE myopathy, SialuriaLikely benign
(Dec 24, 2021)
criteria provided, single submitter
60.
GRCh37:
Chr9:36249368
GRCh38:
Chr9:36249371
GNESialuria, GNE myopathyLikely benign
(Jun 3, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr9:36246391
GRCh38:
Chr9:36246394
GNEV116M, V26M, V85MGNE myopathy, SialuriaUncertain significance
(Jul 9, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr9:36249360
GRCh38:
Chr9:36249363
GNEK29TGNE myopathy, SialuriaUncertain significance
(Sep 28, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr9:36222966
GRCh38:
Chr9:36222969
GNER371W, R422W, R430W, R512W, R481WSialuria, GNE myopathyUncertain significance
(May 21, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr9:36222887
GRCh38:
Chr9:36222890
GNET397I, T456I, T507I, T538I, T448ISialuria, GNE myopathyUncertain significance
(Oct 5, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr9:36217451
GRCh38:
Chr9:36217454
GNEV620M, V694M, V725M, V584M, V643M, V635MGNE myopathy, SialuriaUncertain significance
(Jul 6, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr9:36246096
GRCh38:
Chr9:36246099
GNEC183S, C214S, C124SSialuria, GNE myopathyUncertain significance
(May 21, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr9:36246281
GRCh38:
Chr9:36246284
GNESialuria, GNE myopathyLikely benign
(Jun 12, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr9:36217498
GRCh38:
Chr9:36217501
GNEI678T, I709T, I568T, I627T, I604T, I619TSialuria, GNE myopathyUncertain significance
(Jun 10, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr9:36217422
GRCh38:
Chr9:36217425
GNED629E, D734E, D703E, D593E, D644E, D652ESialuria, GNE myopathyUncertain significance
(Jul 14, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr9:36246023
GRCh38:
Chr9:36246026
GNESialuria, GNE myopathyUncertain significance
(Mar 4, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr9:36246200
GRCh38:
Chr9:36246203
GNESialuria, GNE myopathyLikely benign
(Sep 9, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr9:36217480
GRCh38:
Chr9:36217483
GNER684H, R625H, R574H, R610H, R715H, R633HSialuria, GNE myopathyUncertain significance
(Aug 31, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr9:36236944
GRCh38:
Chr9:36236947
GNEGNE myopathy, SialuriaLikely benign
(Oct 15, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr9:36219902
GRCh38:
Chr9:36219905
GNEGNE myopathy, SialuriaLikely benign
(Oct 10, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr9:36227237
GRCh38:
Chr9:36227240
GNESialuria, GNE myopathyLikely benign
(Oct 8, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr9:36246170
GRCh38:
Chr9:36246173
GNEGNE myopathy, SialuriaLikely benign
(Sep 28, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr9:36246259
GRCh38:
Chr9:36246262
GNER129G, R160G, R70GSialuria, GNE myopathyUncertain significance
(Sep 26, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr9:36220030
GRCh38:
Chr9:36220033
GNESialuria, GNE myopathyUncertain significance
(Sep 20, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr9:36249276-36249277
GRCh38:
Chr9:36249279-36249280
GNEA26F, A57FSialuria, GNE myopathyUncertain significance
(Dec 12, 2021)
criteria provided, single submitter
80.
GRCh37:
Chr9:36236819
GRCh38:
Chr9:36236822
GNESialuria, GNE myopathyLikely benign
(Aug 30, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr9:36218232
GRCh38:
Chr9:36218235
GNEGNE myopathy, SialuriaLikely benign
(Aug 22, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr9:36249371
GRCh38:
Chr9:36249374
GNEGNE myopathy, SialuriaLikely benign
(Sep 3, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr9:36220027
GRCh38:
Chr9:36220030
GNEGNE myopathy, SialuriaLikely benign
(Dec 2, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr9:36218186-36218187
GRCh38:
Chr9:36218189-36218190
GNESialuria, GNE myopathyPathogenic
(Aug 16, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr9:36234015
GRCh38:
Chr9:36234018
GNEG326V, G236V, G185V, G244V, G295VSialuria, GNE myopathyUncertain significance
(Sep 7, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr9:36236975
GRCh38:
Chr9:36236978
GNED149A, D208A, D239ASialuria, GNE myopathyUncertain significance
(Jul 23, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr9:36227386-36227387
GRCh38:
Chr9:36227389-36227390
GNESialuria, GNE myopathyPathogenic
(Jul 21, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr9:36234101
GRCh38:
Chr9:36234104
GNEK157fs, K298fs, K208fs, K267fs, K216fsGNE myopathy, SialuriaPathogenic
(Jul 15, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr9:36217389
GRCh38:
Chr9:36217392
GNEGNE myopathy, SialuriaLikely benign
(Jul 6, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr9:36222762
GRCh38:
Chr9:36222765
GNESialuria, GNE myopathyLikely benign
(Jun 24, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr9:36217426
GRCh38:
Chr9:36217429
GNEV628D, V592D, V651D, V643D, V702D, V733DSialuria, GNE myopathyUncertain significance
(Jul 3, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr9:36276915
GRCh38:
Chr9:36276918
GNESialuria, GNE myopathyLikely benign
(Sep 19, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr9:36223515-36223516
GRCh38:
Chr9:36223518-36223519
GNEGNE myopathy, SialuriaLikely benign
(Feb 9, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr9:36229072
GRCh38:
Chr9:36229075
GNET370I, T280I, T288I, T339I, T229IGNE myopathy, SialuriaUncertain significance
(Sep 7, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr9:36217593
GRCh38:
Chr9:36217596
GNEGNE myopathy, SialuriaUncertain significance
(Dec 28, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr9:36223516-36223517
GRCh38:
Chr9:36223519-36223520
GNESialuria, GNE myopathyLikely benign
(Aug 12, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr9:36223511-36223513
GRCh38:
Chr9:36223514-36223516
GNEGNE myopathy, SialuriaLikely benign
(Aug 19, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr9:36234037
GRCh38:
Chr9:36234040
GNEI229V, I237V, I319V, I178V, I288VSialuria, GNE myopathyUncertain significance
(Jun 7, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr9:36223455
GRCh38:
Chr9:36223458
GNEGNE myopathy, SialuriaLikely benign
(Jun 8, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr9:36223516-36223517
GRCh38:
Chr9:36223519-36223520
GNESialuria, GNE myopathyLikely benign
(Aug 11, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination